Published in Genetics and Environmental Law Weekly, August 18th, 2007
"Inhibitors of enzymes that catalyze the addition and removal of these epigenetic marks thus have therapeutic...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Genetics and Environmental Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.